Detalhe da pesquisa
1.
Author Correction: Tumour lineage shapes BRCA-mediated phenotypes.
Nature
; 577(7789): E1, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31822847
2.
Tumour lineage shapes BRCA-mediated phenotypes.
Nature
; 571(7766): 576-579, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292550
3.
Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(9): 813-824, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846060
4.
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
Mod Pathol
; 33(1): 38-46, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31375766
5.
Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib.
Clin Cancer Res
; 30(4): 687-694, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078898
6.
ATR inhibitor, camonsertib, dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).
J Natl Cancer Inst
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710487
7.
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.
bioRxiv
; 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38766126
8.
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial.
JAMA Oncol
; 9(1): 29-39, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394867
9.
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.
Nat Med
; 29(6): 1400-1411, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277454
10.
Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma.
J Clin Oncol
; 41(33): 5151-5162, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37607324
11.
Precision Oncology: 2022 in Review.
Cancer Discov
; 12(12): 2747-2753, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36458431
12.
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies.
Nat Commun
; 13(1): 7182, 2022 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36418296
13.
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.
Nat Commun
; 13(1): 1450, 2022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35304457
14.
A Performance Comparison of Commonly Used Assays to Detect RET Fusions.
Clin Cancer Res
; 27(5): 1316-1328, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33272981
15.
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib.
Clin Cancer Res
; 27(1): 34-42, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33082208
16.
Evaluation of a shape-based model of human face discrimination using FMRI and behavioral techniques.
Neuron
; 50(1): 159-72, 2006 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-16600863
17.
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations.
Clin Cancer Res
; 26(7): 1624-1632, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31871300
18.
Real-World Outcomes of an Automated Physician Support System for Genome-Driven Oncology.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914018
19.
EZH2 inhibition: it's all about the context.
J Natl Cancer Inst
; 115(11): 1246-1248, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37682251
20.
Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.
Nat Commun
; 13(1): 1936, 2022 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35383193